Improving skeletal muscle insulin sensitivity via beta₂ -agonist administration: a promising strategy to counteract metabolic disease and muscle loss.

ABSTRACT:

SUBMITTER: Dirks ML 

PROVIDER: S-EPMC9321888 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature